Records containing: Optic Atrophy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-08Building Research With Artificial Intelligence in Neuro-Ophthalmology
-
CLINICAL_TRIALS study record update · 2025-04-17Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-arteritic Ischemic Optic Neuropathy
-
CLINICAL_TRIALS study record update · 2025-03-20Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
-
CLINICAL_TRIALS study record update · 2024-03-08A Natural History Study of Neurodegeneration and Optic Atrophy Caused by Ferredoxin Reductase Mutations in Pediatric and Adult Patients
-
CLINICAL_TRIALS study record update · 2024-03-08A Natural History Study of Neurodegeneration and Optic Atrophy Caused by SLC25A46 Mutations in Pediatric and Adult Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-12-30A Prospective, Multicenter, Blinded Reading, Self Controlled, Superiority Priority Clinical Trial of Assisted Fundus Image Diagnosis Software for the Diagnosis of Multiple Eye Fundus Diseases
-
CLINICAL_TRIALS study record update · 2021-07-13Systemic Erythropoietin Injection in Patients Having Optic Atrophy
-
CLINICAL_TRIALS study record update · 2016-08-29Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone, and Incretin Based Therapy
-
CLINICAL_TRIALS study record update · 2014-09-17Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease. It is Self Funded (Patients' Own Funding) Clinical Trial
-
CLINICAL_TRIALS study record update · 2013-05-13A Phase I Open-Label, Dose Escalation Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Patients With Optic Nerve Atrophy (Stratum I) and Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) (Stratum II)